AlphAIAlphAI — Financial news for AI agents
investing.comOCT 282 min read$SCL

Stepan Q3 2026 slides show 18% EBITDA growth, Catalyst savings surge

Stepan Company (NYSE:SCL) reported Q3 2026 adjusted EBITDA growth of 18% to $66.3M, driven by volume growth and margin recovery. Adjusted EPS rose 98% to $0.94, exceeding estimates. Project Catalyst savings exceeded expectations, with Q3 savings run-rate at $23M. Shares are up 51.6% over the past year.

Original reporting
investing.com
Published Oct 28, 2026, 2:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 2:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$SCL
Bullish
high confidence
Mentioned
$SCL
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SCLBullishMed
01

Why it matters

The earnings beat and strong EBITDA growth suggest the restructuring initiative is delivering value, supporting a bullish short‑term outlook.

02

Market read

First report of Stepan's Q3 2026 earnings, providing fresh data for traders.

03

What to watch

The $13M cash restructuring cost and $63M non‑cash charges may weigh on free cash flow outlook.

Relevance 8/10Novelty 8/10Timing: post‑release today

Background

Stepan's Q3 earnings presentation highlighted Project Catalyst savings and operational momentum.

Company-level read

Ticker impact

$SCLBullishHigh confidence
Context

Stepan reported Q3 2026 adjusted EBITDA of $66.3M, up 18% YoY and EPS of $0.94, beating forecasts.

Expected impact

likely upside as market prices in the earnings beat and margin recovery

Evidence & confidence

The company posted 98% EPS growth, beat $0.73 consensus, and shares already rose 2.4% on the news.

Market effects

Sector

Specialty chemicals sector may see broader optimism as Stepan's cost‑saving program shows early results.

Regional

U.S. chemical manufacturers could benefit from demonstrated pricing discipline amid raw‑material volatility.

Global

Limited to North American and European markets where Stepan operates.

Counterpoint

What could challenge this read

If raw‑material costs accelerate, margin gains could be temporary, tempering upside.

Key entities

  • company
    Stepan Company

    Specialty chemicals manufacturer (NYSE:SCL) reporting Q3 2026 results.

Read at source← All news

Also covered by

2 outlets

Related articles

OCT 28
$SCLMed

Stepan Q3 Earnings Call Highlights

Stepan Company (NYSE: SCL) reported Q3 net sales up 12% to $27M, with adjusted EBITDA rising 5% to $11.7M. Management cited higher volume in MCT products and cost pressures from volatile oil markets. Project Catalyst savings exceeded expectations, with $23M quarterly savings and $66M-$70M expected for 2026. Net debt reduced to $536M, and the dividend was raised by 2.5%.

finance.yahoo.com2 min
OCT 28
$SCLMedAI 8/10

Stepan Q3 2026 slides: EPS doubles on volume growth, restructuring

Stepan Company (SCL) reported Q3 2026 adjusted EPS of $0.94, up 98% YoY, driven by 7% volume growth and restructuring savings. Revenue and EPS beat estimates. Shares rose 2.42%. Adjusted EBITDA increased 18% to $66.3M. Project Catalyst restructuring is ahead of schedule, with $23M quarterly savings. Net leverage ratio improved to 2.4x. Free cash flow was $8M, impacted by working capital build.

investing.com2 min
OCT 28
$SCLHigh

Stepan Reports Third Quarter 2026 Results

STEPAN CO (SCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stepan Reports Third Quarter 2026 Results Northbrook, Illinois, October 28, 2026 -- Stepan Company (NYSE: SCL) today reported: Third Quarter 2026 Highlights • Reported net income was $17.8 million, up 64% versus the prior year. Adjusted net income (1) was $21.7 milli

SEC EDGAR 8-K2 min
JUL 31
$SCLMed

Stepan Company Q2 2026 Earnings Call Summary

Strategic Performance Drivers Adjusted EBITDA growth of 45% was driven by a combination of 6% organic volume growth, disciplined pricing execution, and ramping productivity gains. Surfactant performance benefited from broad-based demand across all end markets, specifically led by industrial cleaning, laundry, and oil field sectors. Margin recovery was achieved through the rigorous application of contractual pass-through mechanisms and pricing actions to offset fluctuating raw material costs.

yahoo.com5 min
JUL 29
$SCLMedAI 8/10

Stepan Reports Second Quarter 2026 Results

Stepan (NYSE: SCL) reported Q2 2026 net income of $22.9M, up 102% year over year, and adjusted net income of $27.1M, up 126%. Adjusted EBITDA rose 45% to $74.4M. Net sales increased 15% to $684.1M, with organic volume up 6%. Free cash flow was -$15.0M due to working capital. The company plans to cut about 100 salaried roles under Project Catalyst and expects full-year restructuring charges of $75.0M-$80.0M.

prnewswire.com6 min